Life Healthcare’s share price fell up to 9% after the group announced a R2.9bn adjustment to the “Piramal liability”, tied to potential earnout payments of up to $400m from the disposal of Life Molecular Imaging.
Recent findings that 100% of lupus (autoimmune disease) cases can be linked to the Epstein-Barr virus (EBV), could trigger new treatment for lupus and speed up a vaccine for EBV, which has also been linked to other autoimmune diseases, notes MedicalBrief.
A pioneering public-private healthcare partnership in KwaZulu-Natal, initiated by Dr Michiel Ter Haar, is emerging as a significant solution to South Africa’s overburdened public medical system.
The Competition Commission is investigating Hetero SA for alleged price collusion in bids for SA’s major HIV drug tender involving the TLD combination pill. – BusinessDay (19 Nov 2025)